High incidence of optic disc swelling at very high altitudes

Archives of Ophthalmology

Volumn 126, Issue 5, 2008, Pages 644-650

  Bosch, Martina M ^a   Barthelmes, Daniel ^a   Merz, Tobias M ^b   Bloch, Konrad E ^a   Turk, Alexander J ^a   Hefti, Urs ^c   Sutter, Florian K P ^a   Maggiorini, Marco ^a   Wirth, Maria G ^a   Schoch, Otto D ^d   Landau, Klara ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; IBUPROFEN; NIFEDIPINE; PARACETAMOL; STEROID;

ADULT; ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EYE EXAMINATION; EYE SWELLING; FEMALE; HUMAN; INCIDENCE; MALE; MEDICAL EXAMINATION; OPTIC DISK ANOMALY; OXYGEN SATURATION; PRIORITY JOURNAL; VISUAL ACUITY;

ADULT; ALTITUDE SICKNESS; BRAIN EDEMA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUNTAINEERING; OPTIC DISK; OXYGEN CONSUMPTION; PAPILLEDEMA; PROSPECTIVE STUDIES;

EID: 43549085769     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.5.644     Document Type: Article

References (31)

1. Anholm JD, Powles AC, Downey R III, et al. Operation Everest II: arterial oxygen saturation and sleep at extreme simulated altitude. Am Rev Respir Dis. 1992; 145(4 pt 1):817-826.
2. Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol. 2004;5 (2):136-146.
3. Schneider M, Bernasch D, Weymann J, Holle R, Bartsch P. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc. 2002;34(12):1886-1891.
4. Wagner DR, Fargo JD, Parker D, Tatsugawa K, Young TA. Variables contributing to acute mountain sickness on the summit of Mt Whitney. Wilderness Environ Med. 2006;17(4):221-228.
5. Kellie G. An account of the appearances observed in the dissection of two of three individuals presumed to have perished in the storm of the 3rd, and whose bodies were discovered in the vicinity of the Leith on the morning of the 4th of November 1821, with some reflections on the pathology of the brain. Trans Med Chir Soc Edinb. 1824;1:84-169.
6. Monroe A. Observations on the Structure and Function of the Nervous System. Edinburgh, Scotland: Creech & Johnson; 1783.
7. Rodway GW, Hoffman LA, Sanders MH. High-altitude-related disorders, part I: pathophysiology, differential diagnosis, and treatment. Heart Lung. 2003;32(6):353-359.
8. Walsh FB, Hoyt WF. The ophthalmoscopic diagnosis of papilledema. In: Walsh FB, Hoyt WF, eds. Clinical Neuro-opthalmology. Baltimore, MD: Williams & Wilkins Co; 1969.
9. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91-96.
10. Sampson JB, Cymerman A, Burse RL, Maher JT, Rock PB. Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med. 1983;54(12 pt 1):1063-1073.
11. Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB, Subramanyam CS. Acute mountain sickness. N Engl J Med. 1969;280(4):175-184.
12. Houston CS, Dickinson J. Cerebral form of high-altitude illness. Lancet. 1975;2 (7938):758-761.
13. Dickinson J, Heath D, Gosney J, Williams D. Altitude-related deaths in seven trekkers in the Himalayas. Thorax. 1983;38(9):646-656.
14. Shults WT, Swan KC. High altitude retinopathy in mountain climbers. Arch Ophthalmol. 1975;93(6):404-408.
15. Rennie D, Morrissey J. Retinal changes in Himalayan climbers. Arch Ophthalmol. 1975;93(6):395-400.
16. McFadden DM, Houston CS, Sutton JR, Powles AC, Gray GW, Roberts RS. High-altitude retinopathy. JAMA. 1981;245(6):581-586.
17. MacLaren RE. Retinal haemorrhage in Himalayan mountaineers. J R Army Med Corps. 1995;141(1):25-28.
18. Frayser R, Houston CS, Bryan AC, Rennie ID, Gray G. Retinal hemorrhage at high altitude. N Engl J Med. 1970;282(21):1183-1184.
19. Wiedman M, Tabin GC. High-altitude retinopathy and altitude illness. Ophthalmology. 1999;106(10):1924-1927.
20. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA. 1998;280(22):1920-1925.
21. Kallenberg K, Bailey DM, Christ S, et al. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab. 2006;27(5):1064-1071.
22. Bailey DM, Roukens R, Knauth M, et al. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab. 2006;26(1):99-111.
23. Fischer R, Vollmar C, Thiere M, et al. No evidence of cerebral oedema in severe acute mountain sickness. Cephalalgia. 2004;24(1):66-71.
24. 2. J Appl Physiol. 1994;76 (1):303-313.
25. Mórocz IA, Zientara GP, Gudbjartsson H, et al. Volumetric quantification of brain swelling after hypobaric hypoxia exposure. Exp Neurol. 2001;168(1):96-104.
26. Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure, IV: axoplasmic transport in experimental papilledema. Arch Ophthalmol. 1977;95(8):1458-1462.
27. Sawka MN, Convertino VA, Eichner ER, Schnieder SM, Young AJ. Blood volume: importance and adaptations to exercise training, environmental stresses, and trauma/sickness. Med Sci Sports Exerc. 2000;32(2):332-348.
28. Hackett PH, Rennie D. Avoiding mountain sickness [letter]. Lancet. 1978;2(8096): 938.
29. Roach RC, Houston CS, Honigman B, et al. How well do older persons tolerate moderate altitude? West J Med. 1995;162(1):32-36.
30. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993;118(8):587-592.
31. Ross RT. The random nature of cerebral mountain sickness. Lancet. 1985;1(8435):990-991.